Concepedia

Motoki Okano

MO

Statistics

Publications

4

Citations

99

H-Index

4

Active since

2010

Affiliations

Fujimoto Pharmaceutical Corporation (Japan)(Current)

Osaka University of Pharmaceutical Sciences

Motoki Okano is an author at Fujimoto Pharmaceutical Corporation (Japan) specializing in neuropharmacology, medicine, and psychopharmacology.

Publications per year

2010–2019

4

Publications

4

Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist

Yukihiro Ohno, Motoki Okano, Junta Imaki et al. · Pharmacology Biochemistry and Behavior · 2010 · 30 citations

, , +16

Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity

Toshiko Ishikawa, Motoki Okano, Akiko Minami et al. · Behavioural Brain Research · 2018 · 27 citations · Full text

, , +17

Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson’s Disease

Motoki Okano, Kazue Takahata, Junya Sugimoto et al. · Frontiers in Behavioral Neuroscience · 2019 · 23 citations · Full text

, , +17

Region-specific elevation of D1 receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit/hyperactivity disorder

Yukihiro Ohno, Motoki Okano, Atsushi Masui et al. · Neuropharmacology · 2012 · 19 citations

, , +14

1–4 of 4